Simona Borštnar
Impact in
-
- Protease and Inhibitor Mechanisms
- Breast Cancer Treatment Studies
-
- HER2/EGFR in Cancer Research
- Cancer Treatment and Pharmacology
- Peptidase Inhibition and Analysis
Papers in
- Oncology 16
- Cancer Treatment and Pharmacology 10
- HER2/EGFR in Cancer Research 5
-
- Protease and Inhibitor Mechanisms 8
- Breast Cancer Treatment Studies 6
- Co-authors
- Tanja Čufer (10 shared papers)Ivan Vrhovec (8 shared papers)Nataša Debeljak (3 shared papers)Fran Krstanović (2 shared papers)Branka Svetic (1 shared paper)Tadeja Matos (2 shared papers)Jožica Červek (2 shared papers)Aleksander Sadikov (1 shared paper)
In The Last Decade
Simona Borštnar
41 papers receiving 378 citations
Peers
Comparison fields: 5 of 60
- Cancer Research 129
- Oncology 118
- Pulmonary and Respiratory Medicine 64
- Immunology and Allergy 12
- Genetics 21
Countries citing papers authored by Simona Borštnar
This map shows the geographic impact of Simona Borštnar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Simona Borštnar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Simona Borštnar more than expected).
Fields of papers citing papers by Simona Borštnar
This network shows the impact of papers produced by Simona Borštnar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Simona Borštnar. The network helps show where Simona Borštnar may publish in the future.
Co-authors
The 25 scholars most cited alongside Simona Borštnar, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 43 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 39 | |
| 2 | 2022 | 32 | |
| 3 | 1998 | 26 | |
| 4 | 2002 | 26 | |
| 5 | 2021 | 24 | |
| 6 | Prognostic and predictive value of cathepsins D and L in operable breast cancer patients. | 2005 | 22 |
| 7 | 2009 | 20 | |
| 8 | 2003 | 19 | |
| 9 | 2000 | 18 | |
| 10 | 2008 | 18 | |
| 11 | 2003 | 14 | |
| 12 | 2018 | 13 | |
| 13 | 2017 | 13 | |
| 14 | 2020 | 11 | |
| 15 | 2009 | 7 | |
| 16 | 2022 | 7 | |
| 17 | 2011 | 7 | |
| 18 | 2020 | 7 | |
| 19 | 2021 | 7 | |
| 20 | 2002 | 6 |
About Simona Borštnar
Simona Borštnar is a scholar working on Oncology, Cancer Research, Pulmonary and Respiratory Medicine, Immunology and Allergy and Molecular Biology, having authored 43 papers that have together received 388 indexed citations. Recurring topics across this work include Advanced Breast Cancer Therapies (12 papers), Cancer Treatment and Pharmacology (10 papers), Protease and Inhibitor Mechanisms (8 papers), Cell Adhesion Molecules Research (7 papers), Breast Cancer Treatment Studies (6 papers), HER2/EGFR in Cancer Research (5 papers), Coagulation, Bradykinin, Polyphosphates, and Angioedema (5 papers) and Cannabis and Cannabinoid Research (3 papers). The work is most often cited by research in Cancer Research (129 citations), Oncology (118 citations), Pulmonary and Respiratory Medicine (64 citations), Immunology and Allergy (12 citations) and Genetics (21 citations). Simona Borštnar has collaborated with scholars based in Slovenia, Italy and Spain. Frequent co-authors include Tanja Čufer, Ivan Vrhovec, Nataša Debeljak, Fran Krstanović, Branka Svetic, Tadeja Matos, Jožica Červek, Aleksander Sadikov, Branko Zakotnik and Barbara Gazić. Their work appears in journals such as Journal of Clinical Oncology, The International Journal of Biological Markers, Annals of Oncology, Clinical Breast Cancer and Cancers.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.